A, M., W, N., S, S., T, A., & P, M. (2025). Dosage Regimen Optimization of Ertapenem Against ESBL-Producing Enterobacterales Infection in Critically Ill Patients Using Monte Carlo Simulation. Clinical and translational science, 18(7), e70274. https://doi.org/10.1111/cts.70274
Chicago Style (17th ed.) CitationA, Muangkasem, Nosoongnoen W, Sririttha S, Aramruang T, and Montakantikul P. "Dosage Regimen Optimization of Ertapenem Against ESBL-Producing Enterobacterales Infection in Critically Ill Patients Using Monte Carlo Simulation." Clinical and Translational Science 18, no. 7 (2025): e70274. https://doi.org/10.1111/cts.70274.
MLA (9th ed.) CitationA, Muangkasem, et al. "Dosage Regimen Optimization of Ertapenem Against ESBL-Producing Enterobacterales Infection in Critically Ill Patients Using Monte Carlo Simulation." Clinical and Translational Science, vol. 18, no. 7, 2025, p. e70274, https://doi.org/10.1111/cts.70274.